In this podcast, Dr. Joshua Raub talks about his Hodgkin’s lymphoma diagnosis, undergoing treatment, and managing the wide-ranging effects of the disease.
Speaker disclaimer: While I work in the biotechnology field, my views and opinions are entirely my own and don’t necessarily reflect the views or opinions of my employer.
SPEAKERS
Dr. Joshua Raub currently practices as a medical science liaison with Seagen. Previously, he was the clinical specialist in internal medicine and PGY1 RPD at Detroit Receiving Hospital. He received his PharmD from Wayne State University and PGY1 Residency at The Johns Hopkins Hospital. His accomplishments include ASHP Best Practices award and New Preceptor of the Year. In 2013, Josh was diagnosed with advanced stage Hodgkin’s lymphoma and remains a patient advocate through his remission.
Daniel J. Cobaugh, Pharm.D. FAACT, DABAT is the vice president of publishing at ASHP and the editor-in-chief of AJHP. His responsibilities include executive leadership for the AHFS Drug Information product suite, the ASHP Special Publishing program, and AJHP. He received his Bachelor of Science degree in Pharmacy from the University of Pittsburgh in 1987 and his Doctor of Pharmacy degree, magna cum laude, from Duquesne University in 1989. He completed an ASHP-accredited residency in hospital pharmacy at Mercy Hospital of Pittsburgh and a clinical toxicology fellowship at the Pittsburgh Poison Center/Children's Hospital of Pittsburgh. He practiced as pharmacist-clinical toxicologist and held faculty appointments at the University of Pittsburgh Medical Center and the University of Rochester Medical Center. He was recognized in June 2012 by the University of Pittsburgh School of Pharmacy as a distinguished alumnus and was a 2013 recipient of the University of Pittsburgh 225th Anniversary Medallion.
